Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cost-effectiveness considerations in the treatment of essential thrombocythemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cost-effectiveness considerations in the treatment of essential thrombocythemia.
Cost-effectiveness considerations in the treatment of essential thrombocythemia. Semin Oncol. 2002 Jun; 29(3 Suppl 10):28-32.
View in:
PubMed
subject areas
Antineoplastic Agents
Cost-Benefit Analysis
Fibrinolytic Agents
Humans
Hydroxyurea
Immunologic Factors
Interferon-alpha
Nucleic Acid Synthesis Inhibitors
Quinazolines
Thrombocytosis
authors with profiles
Charles Lee Bennett